Last reviewed · How we verify
QL1012
QL1012 is a small molecule that targets the molecular target.
QL1012 is a small molecule that targets the molecular target. Used for unknown.
At a glance
| Generic name | QL1012 |
|---|---|
| Sponsor | Qilu Pharmaceutical Co., Ltd. |
| Drug class | small molecule |
| Target | unknown |
| Modality | Small molecule |
| Therapeutic area | unknown |
| Phase | Phase 3 |
Mechanism of action
QL1012 works by binding to the molecular target, which results in the desired therapeutic effect.
Approved indications
- unknown
Common side effects
- unknown
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |